|
|
REFERENCES
451.
Chen ST, Hsu CY, Hogan EL, et al: Thromboxane,
prostacyclin, and leukotrienes in cerebral ischemia. Neurology 36:466–470,
1986.
452.
Pieper AA, Verma A, Zhang J, Snyder SH: Poly
(ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20:171–181,
1999.
453.
Marsh WR, Anderson RE, Sundt TM: Effect of hyperglycemia
on brain pH levels in areas of focal incomplete cerebral ischemia in monkeys. J
Neurosurg 65:693–696, 1986.
454.
Chopp M, Welch KMA, Tidwell CD, Helpern JA: Global
cerebral ischemia and intracellular pH during hyperglycemia and hypoglycemia in cats.
Stroke 19:1383–1387, 1988.
455.
Smith M-L, vonHanwehr R, Seisjo BK: Changes in
extra- and intracellular pH in the brain during and following ischemia in hyperglycemic
and moderately hypoglycemic rats. J Cereb Blood Flow Metab 6:574–583, 1986.
456.
Folbergrová J, Memezawa H, Smith M-L, Siesjö
BK: Focal and perifocal changes in tissue energy state during middle cerebral artery
occlusion in normo- and hyperglycemic rats. J Cereb Blood Flow Metab 12:25–33,
1992.
457.
Dawson TM, Dawson VL, Snyder SH: A novel neuronal
messenger molecule in brain: The free radical, nitric oxide. Ann Neurol 32:297–311,
1992.
458.
Beckman JS: The double-edged role of nitric oxide
in brain function and superoxide-mediated injury. J Dev Physiol 15:53–59,
1991.
459.
Iadecola C: Bright and dark sides of nitric oxide
in ischemic brain injury. Trends Neurosci 20:132–139, 1997.
460.
Samdani AF, Dawson TM, Dawson VL: Nitric oxide
synthase in models of focal ischemia. Stroke 28:1283–1288, 1997.
461.
Lipton P: Ischemic cell death in brain neurons.
Physiol Rev 79:1431–1568, 1999.
462.
Fiskum G, Murphy AN, Beal MF: Mitochondria in
neurodegeneration: Acute ischemia and chronic neurodegenerative diseases. J Cereb
Blood Flow Metab 19:351–369, 1999.
463.
Hou ST, MacManus JP: Molecular mechanisms of
cerebral ischemia-induced neuronal death. Int Rev Cytol 221:93–148, 2002.
464.
Velier JJ, Ellison JA, Kikly KK, et al: Caspase-8
and caspase-3 are expressed by different populations of cortical neurons undergoing
delayed cell death after focal stroke in the rat. J Neurosci 19:5932–5941,
1999.
465.
Kawaguchi M, Kimbro JR, Drummond JC, et al: Isoflurane
delays but does not prevent cerebral infarction in rats subjected to focal ischemia.
Anesthesiology 92:1335–1342, 2000.
466.
Du C, Hu R, Csernansky C, et al: Very delayed
infarction after mild focal cerebral ischemia: A role for apoptosis? J Cereb Blood
Flow Metab 16:195–201, 1996.
467.
Dirnagl U, Iadecola C, Moskowitz M: Pathobiology
of ischaemic stroke: An integrated view. Trends Neurosci 22:391–397, 1999.
468.
Zauner A, Daugherty WP, Bullock MR, Warner DS:
Brain oxygenation and energy metabolism: Part I—biological function and pathophysiology.
Neurosurgery 51:289–301, 2002.
469.
Graham S, Chen J: Programmed cell death in cerebral
ischemia. J Cereb Blood Flow Metab 21:99–109, 2001.
470.
Chan PH: Reactive oxygen radicals in signaling
and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2–14, 2001.
471.
Mattson MP, Duan W, Pedersen WA, Culmsee C: Neurodegenerative
disorders and ischemic brain diseases. Apoptosis 6:69–81, 2001.
472.
Abramson NA: Randomized clinical study of thiopental
loading in comatose survivors of cardiac arrest. N Engl J Med 314:397–403,
1986.
473.
Todd MM, Chadwich HC, Shapiro HM, et al: The
neurologic effects of thiopental therapy following cardiac arrest in cats. Anesthesiology
57:76–86, 1982.
474.
Gisvold SE, Safar P, Hendrickx HHL, et al: Thiopental
treatment after global ischemia in pig-tailed monkeys. Anesthesiology 60:88–96,
1984.
475.
Steen PA, Gisvold SE, Milde JH, et al: Nimodipine
improves outcome when given after complete cerebral ischemia in primates. Anesthesiology
62:406–414, 1985.
476.
Tateishi A, Fleischer JE, Drummond JC, et al:
Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest
in cats. Stroke 20:1044–1050, 1989.
477.
Tateishi A, Scheller MS, Drummond JC, et al:
Failure of nimodipine to improve neurologic outcome after eighteen minutes of cardiac
arrest in the cat. Resuscitation 211:191–206, 1991.
478.
Steen PA, Newberg LA, Milde JH, Michenfelder JD:
Cerebral blood flow and neurologic outcome when nimodipine is given after complete
cerebral ischemia in the dog. J Cereb Blood Flow Metab 4:82–87, 1984.
479.
Forsman M, Aarseth HP, Nordby HK, et al: Effects
of nimodipine on cerebral blood flow and cerebrospinal fluid pressure after cardiac
arrest: Correlation with neurologic outcome. Anesth Analg 68:436–443, 1989.
480.
Roine RO, Kaste M, Kinnunen A, et al: Nimodipine
after resuscitation from out-of-hospital ventricular fibrillation: A placebo-controlled,
double-blind, randomized trial. JAMA 264:3171–3177, 1990.
481.
Lidoflazine: Brain Resuscitation Clinical Trial
II Study Group. A randomized clinical study of a calcium-entry blocker (Lidoflazine)
in the treatment of comatose survivors of cardiac arrest. N Engl J Med 324:1225–1231,
1991.
482.
Hypothermia after Cardiac Arrest Study Group:
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.
N Engl J Med 346:549–556, 2002.
483.
Hoffman WE, Cheng MA, Thomas C, et al: Clonidine
decreases plasma catecholamines and improves outcome from incomplete ischemia in
the rat. Anesth Analg 73:460–464, 1991.
484.
Hoffman WE, Thomas C, Albrecht RF: The effect
of halothane and isoflurane on neurologic outcome following incomplete cerebral ischemia
in the rat. Anesth Analg 76:279–283, 1993.
485.
Smith AL, Hoff JT, Nielsen SL, Larson CP: Barbiturate
protection in acute focal cerebral ischemia. Stroke 5:1–7, 1974.
486.
Hoff JT, Smith AL, Hankinson HL, Nielsen SL:
Barbiturate protection from cerebral infarction in primates. Stroke 6:28–33,
1975.
487.
Michenfelder JD, Milde JH, Sundt TM: Cerebral
protection by barbiturate anesthesia. Use after middle cerebral artery occlusion
in Java monkeys. Arch Neurol 33:345–350, 1976.
488.
Lawner PM, Laurent JP, Simeone FA, Fink EA: Effect
of extracranial-intracranial bypass and pentobarbital on acute stroke in dogs. J
Neurosurg 56:92–96, 1982.
489.
Selman WR, Spetzler RF, Roski RA, et al: Barbiturate
coma in focal cerebral ischemia. Relationship of protection to timing of therapy.
J Neurosurg 56:685–690, 1982.
490.
Hoff JT, Nishimura M, Newfield P: Pentobarbital
protection from cerebral infarction without suppression of edema. Stroke 13:623–628,
1982.
491.
Nehls DG, Todd MM, Spetzler RF, et al: A comparison
of the cerebral protective effects of isoflurane and barbiturates during temporary
focal ischemia in primates. Anesthesiology 66:453–464, 1987.
492.
Nussmeier NA, Arlund C, Slogoff S: Neuropsychiatric
complications after cardiopulmonary bypass: Cerebral protection by a barbiturate.
Anesthesiology 64:165–170, 1986.
493.
Shapiro HM: Barbiturates in brain ischemia.
Br J Anaesth 57:82–95, 1985.
494.
Todd MM, Warner DS: A comfortable hypothesis
re-evaluated: Cerebral metabolic rate depression and brain protection during ischemia
[editorial]. Anesthesiology 76:161–164, 1992.
495.
Nakashima K, Todd MM, Warner DS: The relation
between cerebral metabolic rate and ischemic depolarization. Anesthesiology 82:1199–1208,
1995.
496.
Warner DS, Takaoka S, Wu B, et al: Electroencephalographic
burst suppression is not required to elicit maximal neuroprotection from pentobarbital
in a rat model of focal cerebral ischemia. Anesthesiology 84:1475–1484, 1996.
497.
Busto R, Dietrich WD, Globus MY-T, et al: Small
differences in intraischemic brain temperature critically determine the extent of
ischemic neuronal injury. J Cereb Blood Flow Metab 7:729–738, 1987.
498.
Sano T, Drummond JC, Patel PM, et al: A comparison
of the cerebral protective effects of isoflurane and mild hypothermia in a model
of incomplete forebrain ischemia in the rat. Anesthesiology 76:221–228, 1992.
499.
Buchan A, Pulsinelli WA: Hypothermia but not
the N-methyl-D-aspartate
antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient
global ischemia. J Neurosci 10:311–316, 1990.
500.
Warner DS, Zhou J, Ramani R, Todd MM: Reversible
focal ischemia in the rat: Effects of halothane, isoflurane, and methohexital anesthesia.
J Cereb Blood Flow Metab 11:794–802, 1991.
501.
Drummond JC, Cole DJ, Patel PM, Reynolds LW:
Focal cerebral ischemia during anesthesia with etomidate, isoflurane or thiopental:
A comparison of the extent of cerebral injury. Neurosurgery 37:742–749, 1995.
502.
Gisvold SE, Safar P, Hendrick HHL, et al: Thiopental
treatment after global brain ischemia in pigtailed monkeys. Anesthesiology 60:88–96,
1984.
503.
Cole DJ, Cross LM, Drummond JC, et al: Thiopentone
and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury
in rats. Can J Anaesth 48:807–814, 2001.
504.
Baughman VL, Hoffman WE, Miletich DJ, et al:
Neurologic outcome in rats following incomplete cerebral ischemia during halothane,
isoflurane or N2
O. Anesthesiology 69:192–198, 1988.
505.
Soonthan-Brant V, Patel PM, Drummond JC, et al:
Fentanyl does not increase brain injury after focal cerebral ischemia in rats.
Anesth Analg 88:49–55, 1999.
506.
Mackensen GB, Nellgard B, Kudo M, et al: Peri-ischemic
cerebral blood flow (CBF) does not explain beneficial effects of isoflurane on outcome
from near complete forebrain ischemia in rats. Anesthesiology 93:1102–1106,
2000.
507.
Nellgard B, Mackensen GB, Pineda J, et al: Anesthetic
effects on cerebral metabolic rate predict histologic outcome from near-complete
forebrain ischemia in the rat. Anesthesiology 93:431–436, 2000.
508.
Kawaguchi M, Kimbro JR, Drummond JC, et al: Effects
of isoflurane on neuronal apoptosis in rats subjected to focal ischemia. J Neurosurg
Anesthesiol 12:385, 2000.
509.
Warner DS, Desphande JK, Wieloch T: The effect
of isoflurane on neuronal necrosis following near-complete forebrain ischemia in
the rat. Anesthesiology 64:19–23, 1986.
510.
Baughman VL, Hoffman WE, Miletich DJ, et al:
Neurologic outcome in rats following incomplete cerebral ischemia during halothane,
isoflurane, or N2
O. Anesthesiology 69:192–198, 1988.
511.
Milde LN, Milde JH, Lanier WL, et al: Comparison
of the effects of isoflurane and thiopental on neurologic outcome and neuropathology
after temporary focal cerebral ischemia in primates. Anesthesiology 69:905–913,
1988.
512.
Gelb AW, Boisvert DP, Tang C, et al: Primate
brain tolerance to temporary focal cerebral ischemia during isoflurane- or sodium
nitroprusside-induced hypotension. Anesthesiology 70:678–683, 1989.
513.
Ruta TS, Drummond JC, Cole DJ: A comparison of
the area of histochemical dysfunction after focal cerebral ischaemia during anaesthesia
with isoflurane and halothane in the rat. Can J Anaesth 38:129–135, 1991.
514.
Warner DS, Todd MM, McFarlane C, et al: Sevoflurane
and halothane reduce focal ischemic brain damage in the rat: Possible influence
on thermoregulation. Anesthesiology 79:985–992, 1993.
515.
Warner DS, McFarlane C, Todd MM, et al: Sevoflurane
and halothane reduce focal ischemic brain damage in the rat. Anesthesiology 79:985–992,
1993.
516.
Werner C, Mollenberg O, Kochs E, Schulte JE:
Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in
rats. Br J Anaesth 75:756–760, 1995.
517.
Engelhard K, Werner C, Reeker W, et al: Desflurane
and isoflurane improve neurological outcome after incomplete cerebral ischaemia in
rats. Br J Anaesth 83:415–421, 1999.
518.
Ravussin P, deTribolet N: Total intravenous anesthesia
with propofol for burst suppression in cerebral aneurysm surgery: Preliminary report
of 42 patients. Neurosurgery 32:236–240, 1993.
519.
Ridenour TR, Warner DS, Todd MM, Glonet TX: Comparative
effects of propofol and halothane on outcome from temporary middle cerebral artery
occlusion in the rat. Anesthesiology 76:807–812, 1992.
520.
Gelb AW, Bayona NA, Wilson JX, Cechetto DF: Propofol
anesthesia compared to awake reduces infarct size in rats. Anesthesiology 96:1183–1190,
2002.
521.
Pittman JE, Sheng H, Pearlstein RD, et al: Comparison
of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarction
size after temporary focal ischemia in the rat. Anesthesiology 87:1139–1144,
1997.
522.
Batjer HH, Frankfurt AI, Purdy PD, et al: Use
of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical
treatment of large and giant cerebral aneurysms. J Neurosurg 68:234–240, 1988.
523.
Watson JC, Drummond JC, Patel PM, et al: An assessment
of the cerebral protective effects of etomidate in a model of incomplete forebrain
ischemia in the rat. Neurosurgery 30:540–544, 1992.
524.
Sano T, Patel PM, Drummond JC, Cole DJ: A comparison
of the cerebral protective effects of etomidate, thiopental and isoflurane in a model
of forebrain ischemia in the rat. Anesth Analg 76:990–997, 1993.
525.
McKay L, Drummond JC, Cole DJ, et al: Effect
of nitric oxide on focal cerebral ischemic injury during etomidate or halothane anesthesia
in rats [abstract]. Anesthesiology 85:A1181, 1996.
526.
Nebauer AE, Doenicke A, Hoernecke R, et al: Does
etomidate cause haemolysis? Br J Anaesth 69:58–60, 1992.
527.
Wolff DJ, Datto GA, Samatovicz RA, Tempsick RA:
Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole
and phenylimidazoles. J Biol Chem 268:9425–9429, 1993.
528.
Samson D, Batjer HH, Bowman G, et al: A clinical
study of the parameters and effects of temporary arterial occlusion in the management
of intracranial aneurysms. Neurosurgery 34:22–28, discussion 28–29,
1994.
529.
Pickard JD, Murray GD, Illingworth R, et al:
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage:
British Aneurysm Nimodipine Trial. BMJ 298:636–642, 1989.
530.
Gelmers HJ, Gorter K, DeWeerdt CJ, Wiezer HJA:
A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 318:203–207,
1988.
531.
Rosenbaum D, Zabramski J, Frey J, et al: Early
treatment of ischemic stroke with a calcium antagonist. Stroke 22:437–441,
1991.
532.
Trust Study Group: Randomised, double-blind,
placebocontrolled trial of nimodipine in acute stroke. Lancet 336:1205–1209,
1990.
533.
Wise G, Sutter R, Burkholder J: The treatment
of brain ischemia with vasopressor drugs. Stroke 3:135–140, 1972.
534.
Cole DJ, Drummond JC, Osborne TN, Matsumura J:
Hypertension and hemodilution during cerebral ischemia reduce brain injury and edema.
Am J Physiol 259:H211–H217, 1990.
535.
Young WL, Solomon RA, Pedley TA, et al: Direct
cortical EEG monitoring during temporary vascular occlusion for cerebral aneurysm
surgery. Anesthesiology 71:794–799, 1989.
536.
Soloway M, Nadel W, Albin MS, White RJ: The effect
of hyperventilation on subsequent cerebral infarction. Anesthesiology 29:975–980,
1968.
537.
Waltz AG, Sundt TM, Michenfelder JD: Cerebral
blood flow during carotid endarterectomy. Circulation 45:1091–1096, 1972.
538.
Christensen MS, Paulson OB, Olesen J, et al:
Cerebral apoplexy (stroke) treated with or without prolonged artificial hyperventilation:
1. Cerebral circulation, clinical course, and cause of death. Stroke 4:568–619,
1973.
539.
Michenfelder JD, Sundt TM: The effect of PaCO2
on the metabolism of ischemic brain in squirrel monkeys. Anesthesiology 38:445–453,
1973.
540.
Michenfelder JD, Milde JH: Failure of prolonged
hypocapnia, hypothermia, or hypertension to favorably alter acute stroke in primates.
Stroke 8:87–91, 1977.
541.
Ruta TS, Drummond JC, Cole DJ: The effect of
acute hypocapnia on local cerebral blood flow during middle cerebral artery occlusion
in isoflurane anesthetized rats. Anesthesiology 78:134–140, 1993.
542.
Busto R, Globus MY-T, Dietrich WD, et al: Effect
of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty
acids in rat brain. Stroke 20:904–910, 1989.
543.
Minamisawa H, Smith M-L, Siesjö BK: The
effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and
15 minutes of forebrain ischemia. Ann Neurol 28:26–33, 1990.
544.
Welsh FA, Sims RE, Harris VA: Mild hypothermia
prevents ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab 10:557–563,
1990.
545.
Ridenour TR, Warner DS, Todd MM, McAllister AC:
Mild hypothermia reduces infarct size resulting from temporary but not permanent
focal ischemia in rats. Stroke 23:733–738, 1992.
546.
Boris-Möller F, Smith M-L, Siesjö BK:
Effects of hypothermia on ischemic brain damage: A comparison between preischemic
and postischemia cooling. Neurosci Res Commun 5:87–94, 1989.
547.
Busto R, Dietrich WD, Globus MY-T, Ginsberg MD:
Post-ischemic moderate hypothermia inhibits CA1 hippocampal neuronal ischemic injury.
Neurosci Lett 101:299–304, 1989.
548.
Baker CJ, Onesti MT, Solomon RA: Reduction by
delayed hypothermia of cerebral infarction following middle cerebral artery occlusion
in the rat: A time-course study. J Neurosurg 77:438–444, 1992.
549.
Coimbra C, Drake M, Boris-Moller F, Wieloch T:
Long-lasting neuroprotective effect of postischemic hypothermia and treatment with
an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic processes
after ischemia. Stroke 27:1578–1585, 1996.
550.
Ginsberg MD, Sternau LL, Globus MY-T, et al:
Therapeutic modulation of brain temperature: Relevance to ischemic brain injury.
Cerebrovasc Brain Metab Rev 4:189–225, 1992.
551.
Hindman BJ, Todd MM, Gelb AW, et al: Mild hypothermia
as a protective therapy during intracranial aneurysm surgery: A randomized prospective
pilot trial. Neurosurgery 44:23–32, discussion 32–33, 1999.
552.
Steiner T, Friede T, Aschoff A, et al: Effect
and feasibility of controlled rewarming after moderate hypothermia in stroke patients
with malignant infarction of the middle cerebral artery. Stroke 32:2833–2835,
2001.
553.
Georgiadis D, Schwarz S, Kollmar R, Schwab S:
Endovascular cooling for moderate hypothermia in patients with acute stroke. Stroke
32:2550–2553, 2001.
554.
Krieger DW, DeGeorgia MA, Abou-Chebl A, et al:
Cooling for acute ischemic brain damage (COOL AID). Stroke 32:1847–1854,
2001.
555.
Schwab S, Georgiadis D, Berrouschot J, et al:
Feasibility and safety of moderate hypothermia after massive hemispheric infarction.
Stroke 32:2033–2035, 2001.
556.
Kammersgaard LP, Rasmussen BH, Jorgensen HS, et
al: Feasibility and safety of inducing modest hypothermia in awake patients with
acute stroke through surface cooling: A case-control study. Stroke 31:2251–2256,
2000.
557.
Bouma GJ, Muizelaar JP, Choi SC, et al: Cerebral
circulation and metabolism after severe traumatic brain injury: The elusive role
of ischemia. J Neurosurg 75:685–693, 1991.
558.
Graham DI, Ford I, Adams JH, et al: Ischaemic
brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg
Psychiatry 52:346–350, 1989.
559.
Marion DW, Obrist WD, Carlier PM, et al: The
use of moderate therapeutic hypothermia for patients with severe head injuries:
A preliminary report. J Neurosurg 79:354–362, 1993.
560.
Shiozaki T, Sugimoto H, Taneda M, et al: Effect
of mild hypothermia on uncontrollable intracranial hypertension after severe head
injury. J Neurosurg 79:363–368, 1993.
561.
Clifton GL, Allen S, Barrodale P, et al: A phase
II study of moderate hypothermia in severe brain injury. J Neurotrauma 10:263–273,
1993.
562.
Metz C, Holzschuh M, Bein T, et al: Moderate
hypothermia in patients with severe head injury: Cerebral and extracerebral effects.
J Neurosurg 85:533–541, 1996.
563.
Clifton GL, Miller ET, Choi SC, et al: Lack of
effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556–563,
2001.
564.
Kuroiwa T, Bonnekoh P, Hossmann KA: Prevention
of postischemic hyperthermia prevents ischemic injury of CA1 neurons in gerbils.
J Cereb Blood Flow Metab 10:550–556, 1990.
565.
Baena RC, Busto R, Dietrich WD, et al: Hyperthermia
delayed by 24 hours aggravates neuronal damage in rat hippocampus following global
ischemia. Neurology 48:768–773, 1997.
566.
Pulsinelli WA, Waldman S, Rawlinson D, Plum F:
Moderate hyperglycemia augments ischemic brain damage: A neuropathologic study
in the rat. Neurology 32:1239–1246, 1982.
567.
Lanier WL, Stangland KJ, Scheithauer BW, et al:
The effects of dextrose infusion and head position on neurologic outcome after complete
cerebral ischemia in primates: Examination of a model. Anesthesiology 66:39–48,
1987.
568.
Drummond JC, Moore SS: The influence of dextrose
administration on neurologic outcome after temporary spinal cord ischemia in the
rabbit. Anesthesiology 70:64–70, 1989.
569.
Nakakimura K, Fleischer JE, Drummond JC, et al:
Glucose administration prior to cardiac arrest significantly worsens neurologic
outcome in cats. Anesthesiology 72:1005–1011, 1990.
570.
Vannucci RC, Brucklacher RM, Vannucci SJ: The
effect of hyperglycemia on cerebral metabolism during hypoxiaischemia in the immature
rat. J Cereb Blood Flow Metab 16:1026–1033, 1996.
571.
Müllner M, Sterz F, Binder M, et al: Blood
glucose concentration after cardiopulmonary resuscitation influences functional neurological
recovery in human cardiac arrest survivors. J Cereb Blood Flow Metab 17:430–436,
1997.
572.
Weir CJ, Murray GD, Dyker AG, Lees KR: Is hyperglycaemia
an independent predictor of poor outcome after acute stroke? Results of a long term
follow up study. BMJ 314:1303–1306, 1997.
573.
Longstreth WT, Diehr P, Cobb LA, et al: Neurologic
outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation.
Neurology 36:1186–1191, 1986.
574.
Woo J, Lam CWK, Kay R, et al: The influence of
hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality
after acute stroke. Arch Neurol 47:1174–1177, 1990.
575.
Frasco P, Croughwell N, Blumenthal J, et al:
Association between blood glucose level during cardiopulmonary bypass and neuropsychiatric
outcome [abstract]. Anesthesiology 75:A55, 1991.
576.
Toni D, Sacchetti ML, Argentino C, et al: Does
hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J
Neurol 239:382–386, 1992.
577.
Matchar DB, Divine GW, Heyman A, Feussner JR:
The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med
117:449–456, 1992.
578.
Archer DP: The role of bloodletting in the prevention
and treatment of asthenic apoplexy. J Neurosurg Anesthesiol 6:51–53, 1994.
579.
Lenzi GL, Frackowiak RSJ, Jones T: Cerebral oxygen
metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow
Metab 2:321–335, 1982.
580.
Paulson OB: Regional cerebral blood flow in apoplexy
due to occlusion of the middle cerebral artery. Neurology 20:63–77, 1970.
581.
Agnoli A, Fieschi C, Bozzao L, et al: Autoregulation
of cerebral blood flow. Studies during drug-induced hypertension in normal subjects
and in patients with cerebral vascular diseases. Circulation 38:800–812, 1968.
582.
Fieschi C, Agnoli A, Prencipe M, et al: Impairment
of the regional vasomotor response of cerebral vessels to hypercarbia in vascular
diseases. Eur Neurol 2:13–30, 1969.
583.
Olsen TS: Regional cerebral blood flow after
occlusion of the middle cerebral artery. Acta Neurol Scand 73:321–337, 1986.
584.
Ballotta E, Da Giau G, Baracchini C, et al: Early
versus delayed carotid endarterectomy after a non-disabling ischemic stroke: A prospective,
randomized study. Surgery 131:287–293, 2002.
585.
Finnerty FA, Witkin L, Fazekas JF: Cerebral hemodynamics
during cerebral ischemia induced by acute hypotension. J Clin Invest 33:1227–1232,
1954.
586.
Njemanze PC: Critical limits of pressure-flow
relation in the human brain. Stroke 23:1743–1747, 1992.
587.
Vorstrup S, Barry DI, Jarden JO, et al: Chronic
antihypertensive treatment in the rat reverses hypertension-induced changes in cerebral
blood flow autoregulation. Stroke 15:312–318, 1984.
588.
Toyoda K, Fujii K, Ibayashi S, et al: Attenuation
and recovery of brain stem autoregulation in spontaneously hypertensive rats. J
Cereb Blood Flow Metab 18:305–310, 1998.
589.
Paulson OB, Vorstrup S, Anderson AR, et al: Converting
enzyme inhibition resets cerebral autoregulation at lower blood pressure. J Hypertens
3:S487-S488, 1985.
590.
Arbit E, DiResta GR, Bedford RF, et al: Intraoperative
measurement of cerebral and tumor blood flow with laser-Doppler flowmetry. Neurosurgery
24:166–170, 1989.
591.
Schregel W, Geibler C, Winking M, et al: Transcranial
Doppler monitoring during induction of anesthesia: Effects of propofol, thiopental,
and hyperventilation in patients with large malignant brain tumors. J Neurosurg
Anesthesiol 5:86–93, 1993.
592.
Shin JH, Lee HK, Kwun BD, et al: Using relative
cerebral blood flow and volume to evaluate the histopathologic grade of cerebral
gliomas: Preliminary results. AJR Am J Roentgenol 179:783–789, 2002.
593.
Bedford RF, Morris L, Jane JA: Intracranial hypertension
during surgery for supratentorial tumor: Correlation with preoperative computed
tomography scans. Anesth Analg 61:430–433, 1982.
594.
Yeung WTI, Lee T-Y, Maestro RFD, et al: Effect
of steroids on iopamidol blood-brain transfer constant and plasma volume in brain
tumors measured with X-ray computed tomography. J Neuro-oncology 18:53–60,
1994.
595.
Van Roost D, Hartmann A, Quade G: Changes of
cerebral blood flow following dexamethasone treatment in brain tumour patients.
Acta Neurochir (Wien) 143:37–43, 2001.
596.
Jarden JO, Dhawan V, Moeller JR, et al: The time
course of steroid action on blood-to-brain and blood-to-tumor transport of 82
Rb:
A positron emission tomographic study. Ann Neurol 25:239–245, 1989.
597.
Wasterlain CG: Mortality and morbidity from serial
seizures: An experimental study. Epilepsia 15:155–176, 1974.